Stock Events

Stock Events

CytomX Therapeutics (6C1.F) Q4 2024 Earnings

7NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-0.16

-0.05

0.05

0.16

Details

Expected EPS

-0.15954298568

Actual EPS

0.06480670000000001

Surprise EPS

0.22

Surprise Percent

+140.62%

Description

CytomX Therapeutics (6C1.F) has reported earnings of 0.06480670000000001 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.